Physician profile
Rene Lim
NPI 1639100498
$2,830.00
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $945 · 2020: $108 · 2021: $517 · 2022: $710 · 2023: $521 · 2024: $29.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $692.45 | 2021-2023 | Arexvy, Bexsero, Shingrix |
| Amgen INC. | $469.35 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $379.34 | 2019-2023 | Vaxneuvance, M-M-R II, Gardasil 9 |
| Novo Nordisk INC | $253.24 | 2019-2022 | |
| Sanofi Pasteur INC. | $192.21 | 2019-2023 | |
| Pfizer INC. | $186.00 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $162.64 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $124.00 | 2022-2024 | Dupixent |
| Lilly USA, LLC | $86.79 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.40 | 2020-2022 | |
| Phadia US INC. | $55.77 | 2019-2022 | |
| Daiichi Sankyo INC. | $46.84 | 2019 | |
| Cranial Technologies, INC | $34.31 | 2023 | Doc Band |
| Janssen Pharmaceuticals, INC | $24.93 | 2020 | |
| Amarin Pharma, INC. | $16.90 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.96 | 2019 | |
| Abbott Laboratories | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.